CEO Eric M. Green to retire; West reaffirms 2026 guidance

WEST PHARMACEUTICAL SERVICES INC

Eric M. Green informed Board on March 6, 2026 of plan to retire as President, CEO and Chair after successor is hired, expected H2 2026.
Board is engaging a leading executive recruiting firm to find successor; transition aimed at smooth handoff.
Company reaffirms 2026 financial guidance issued on February 12, 2026; no change to outlook.
Green served as CEO since April 2015, Chair since May 2022; TSR ~350% during his 11-year tenure and sales more than doubled.
Lead Independent Director Robert F. Friel thanked Green for his service and highlighted company's innovation and pandemic response.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.